1 From University of Washington/Seattle Cancer Care Alliance; University of Michigan Comprehensive Cancer Center; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Dana-Farber/Brigham and Women’s Cancer Center; Moffitt Cancer Center; Fox Chase Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Stanford Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Vanderbilt-Ingram Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Huntsman Cancer Institute at the University of Utah; Roswell Park Cancer Institute; City of Hope Comprehensive Cancer Center; University of Colorado Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Memorial Sloan Kettering Cancer Center; and National Comprehensive Cancer Network.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide recommendations for selecting individuals for lung cancer screening, and for evaluation and follow-up of nodules found during screening, and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights focus on the major updates to the 2015 NCCN Guidelines for Lung Cancer Screening, which include a revision to the recommendation from category 2B to 2A for one of the high-risk groups eligible for lung cancer screening. For low-dose CT of the lung, the recommended slice width was revised in the table on “Low-Dose Computed Tomography Acquisition, Storage, Interpretation, and Nodule Reporting.”
Provided content development and/or authorship assistance.